Innovus (INNV) Gains 75% in Past Week.
After Rough Sledding Post Reverse Split, Client Innovus Receives Buyout Offer From Nasdaq Listed Ayto Biosciences (AYTU).
Click here to receive post-merger report.
INNOVUS LIVE CHART
TRADING...
AYTU (ATYU) ‘Team’ Letter on Innovus (INNV) Acquisition.
Aytu Team:
I’m pleased to share with you some exciting, transformational news about Aytu BioScience that we announced publicly this morning.
This morning, the company...
Newsworthy: Fortress Bio (FBIO) $1.73, Gets $20 Price Target!
Adding Fortress to Biotech Stock Review Watch List @ $1.73.
Misunderstood by Wall Street which tends to 'over-analyze' on occasion, we think the Fortress Bio...
Cougar Biotechnology. A $500,000 Investment Acquired for $1 Billion.
Consider the case of Cougar Biotechnology, a biopharmaceutical company that Rosenwald founded. Rosenwald identified a specialist health care company in the United Kingdom that...
SEC Charges TherapeuticsMD (TXMD) $2.80 With Regulation FD Violations
Washington D.C., Aug. 20, 2019 —
The Securities and Exchange Commission today charged TherapeuticsMD Inc., a pharmaceutical company headquartered in Boca Raton, Florida, with violations...
Mustang Bio (MBIO) Investor Presentation
August 2019
Mustang (MBIO) Balance Sheet Bolstered With $83 Million in Cash.
Mustang Bio Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
NEW YORK, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ:...
Emerald Organic Products, Inc. (EMOR) Announces Exclusive Licensing Agreement With PetVivo Holdings Inc. (PETV).
New York, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Emerald Organic Products, Inc. (OTC:EMOR) ("Emerald" or the "Company") is pleased to announce that it...
Dalrada (DFCO) Legal Counsel
CONTINUOUSLY UPDATED
Dalrada Financial Adds Robbe to Board of DirectorsDalrada Financial Corporation Hires Fletcher Robbe International
Dalrada Financial Adds Robbe to Board of Directors
HENDERSON, Nev., Aug....
Biotech Stock Review Adds Hancock Jaffe (HJLI) $1.05 to Watch List.
Adding to Watch List on Heels of 90 Day Results, From First Small 'In-Man' Trial to Treat Chronic Venous Insufficiency affecting the legs, with...















